A new warning from the FDA for GLP1 drugs including Ozempic and Wegovy
In general, when a person prepares for a surgery, the guidance is to fast before going under anesthesia– but for patients, on gGLP-1's there may still be gastric juices, in the stomach, since the ...
A stronger Ozempic, Wegovy sales boom, and Hims' generic weight loss drug: Pharma news roundup
Denmark-based Novo Nordisk teased some new details about a potential Ozempic successor during a call with investors on Tuesday. Sales of the company’s current blockbuster weight loss drug, Wegovy, ...
FDA adds new warning to weight loss drugs including Wegovy
The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...
Novo Nordisk's Wegovy weight-loss drug sales beat forecast, shares jump
Novo Nordisk reported forecast-beating third-quarter sales of its popular Wegovy weight-loss drug on Wednesday, reassuring ...
Novo Nordisk Posts Mixed Results, Adding to Jitters About Weight-Loss Drugs
When Novo Nordisk reports earnings Wednesday morning, investors will be seeking reassurance that they haven’t overestimated ...
Is Novo Nordisk A/S (NVO) The Best European Stock To Buy According to Hedge Funds?
We recently compiled a list of the 8 Best European Stocks To Buy According to Hedge Funds. In this article, we are going to ...
New study reveals another benefit in using Novo Nordisk’s Wegovy in obesity
Novo Nordisk's (NVO) semaglutide, marketed as Wegovy for obesity, shows promise in reducing joint disease symptoms in ...